open access

Vol 80, No 5 (2012)
ORIGINAL PAPERS
Published online: 2012-08-27
Submitted: 2013-02-22
Get Citation

The use of multi-color flow cytometry for identification of functional markers of nTregs in patients with severe asthma

Łukasz Kraszula, Makandjou-Ola Eusebio, Maciej Kupczyk, Piotr Kuna, Mirosława Pietruczuk
Pneumonol Alergol Pol 2012;80(5):389-401.

open access

Vol 80, No 5 (2012)
ORIGINAL PAPERS
Published online: 2012-08-27
Submitted: 2013-02-22

Abstract

Introduction: At present, severe asthma is a particular clinical problem. An important role is attributed to dysfunction of nTreg subpopulations of lymphocytes in the pathogenesis of asthma. Therefore, the purpose of this study was to identify markers of nTreg cell function in patients with severe and mild to moderate asthma.
Material and methods: The study included sixty patients with asthma (30 with severe and 30 with mild to moderate asthma). The control group comprised 30 healthy volunteers. The diagnosis of asthma was confirmed accordance with generally accepted recommendations (GINA 2008). nTreg immunophenotype CD4/CD25/CD127/FoxP3/GITR/CD152/CCR5/ /CCR7 was evaluated by multicolor flow cytometry.
Results:
We showed a significant reduction in the percentage of nTreg (76%) cells and the expression of CD152 (46.2%) in patients with severe asthma compared with mild-moderate asthma (85.5% and 86.7%; p < 0.05). It was observed that the transcription factor FoxP3 expression in nTreg cells positively correlated with FEV1 in patients with severe asthma (r = 0.53; p < 0.05). It was also found that the ratio nTregCCR5&lowast;/TeffCCR5&lowast; was significantly reduced in patients with severe asthma (0.91) compared with mild-moderate (1.58) asthma and control groups (1.55; p < 0.001).
Conclusions:
There are phenotypic differences in nTreg lymphocytes between patients with severe and mild-moderate asthma. This fact may confirm nTreg cell dysfunction and indicate that the potential markers (FoxP3, CD152, CCR5), can be used to monitor the effectiveness of treatment of bronchial asthma, especially severe disease.

Abstract

Introduction: At present, severe asthma is a particular clinical problem. An important role is attributed to dysfunction of nTreg subpopulations of lymphocytes in the pathogenesis of asthma. Therefore, the purpose of this study was to identify markers of nTreg cell function in patients with severe and mild to moderate asthma.
Material and methods: The study included sixty patients with asthma (30 with severe and 30 with mild to moderate asthma). The control group comprised 30 healthy volunteers. The diagnosis of asthma was confirmed accordance with generally accepted recommendations (GINA 2008). nTreg immunophenotype CD4/CD25/CD127/FoxP3/GITR/CD152/CCR5/ /CCR7 was evaluated by multicolor flow cytometry.
Results:
We showed a significant reduction in the percentage of nTreg (76%) cells and the expression of CD152 (46.2%) in patients with severe asthma compared with mild-moderate asthma (85.5% and 86.7%; p < 0.05). It was observed that the transcription factor FoxP3 expression in nTreg cells positively correlated with FEV1 in patients with severe asthma (r = 0.53; p < 0.05). It was also found that the ratio nTregCCR5&lowast;/TeffCCR5&lowast; was significantly reduced in patients with severe asthma (0.91) compared with mild-moderate (1.58) asthma and control groups (1.55; p < 0.001).
Conclusions:
There are phenotypic differences in nTreg lymphocytes between patients with severe and mild-moderate asthma. This fact may confirm nTreg cell dysfunction and indicate that the potential markers (FoxP3, CD152, CCR5), can be used to monitor the effectiveness of treatment of bronchial asthma, especially severe disease.
Get Citation

Keywords

asthma; nTreg; FoxP3; CD152; GITR; CCR5; CCR7

About this article
Title

The use of multi-color flow cytometry for identification of functional markers of nTregs in patients with severe asthma

Journal

Advances in Respiratory Medicine

Issue

Vol 80, No 5 (2012)

Pages

389-401

Published online

2012-08-27

Bibliographic record

Pneumonol Alergol Pol 2012;80(5):389-401.

Keywords

asthma
nTreg
FoxP3
CD152
GITR
CCR5
CCR7

Authors

Łukasz Kraszula
Makandjou-Ola Eusebio
Maciej Kupczyk
Piotr Kuna
Mirosława Pietruczuk

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl